期刊文献+

肝细胞癌与癌周细胞Fas抗原及其配体的表达

The expressions of Fas and its ligand on tumor cells and noncancerous liver cells surrounding tumor tissue
暂未订购
导出
摘要 目的 探讨Fas系统在肝细胞癌免疫逃逸及免疫反击中的作用。方法 采用间接免疫荧光流式细胞术检测 2 0例肝细胞癌病人的肿瘤细胞和癌周肝细胞Fas抗原及其配体的表达水平。结果 肿瘤细胞Fas及其配体的表达水平分别为 31.72± 12 .74和 7.14± 6 .6 8,癌周细胞分别为 2 3.85± 8.36和 4.13± 3.82 ,肿瘤细胞与癌周细胞相比Fas与Fas配体的表达水平均显著上调 (P <0 .0 1)。结论 下调Fas表达的免疫逃逸机制在肝细胞癌不起主要作用 ,通过Fas系统介导免疫活性细胞凋亡的“Fas反击”机制可能在肝细胞癌具有重要作用。 Objective To probe the potential role of Fas system in immune escape and counterattack involved in HCC.Methods The expression levels of Fas and Fas L(ligand) on tumor cells and noncancerous liver cells surrounding tumor tissue were detected by means of indirect fluorescent immunoassay flow cytometry.Results The expression levels of Fas and Fas L on tumor cells were 31.72±12.74 and 7.14±6.68,respectively;on noncancerous liver cells,23.85±8.36 and 4.13±3.82,respectively.Conclusions The expression levels of both Fas and Fas L on tumor cells were up regulated as compared with that on noncancerous liver cells from same patients,which indicated that the mechanism of down regulating of Fas by which tumor cells made immune escape was less important,whereas the “Fas counterattack” mechanism against antitumor immune effect cells had an important role in HCC. [
出处 《前卫医药杂志》 2001年第2期111-113,共3页 Qianwei Journal of Medicine & Pharmacy
关键词 FAS抗原 FAS配体 肝细胞癌组织 肿瘤免疫 流式细胞术 Fas Fas ligand(Fas L) Hepatocellular carcinoma tissue Tumor immunology Flow cytometry
  • 相关文献

参考文献15

  • 1Nagata S, Golstein P. The Fas death factor. Science, 1995,27:1449
  • 2Mitsuo N, Nakajima Y, Hisanage M, et al. The alteration of Fas receptor and ligand system in hepatocellular carcinoma:how do hepatoma cells escape from the host immune surveillance in vivo? Hepatology,1999, 30(2) :413
  • 3Rimoldi D,Hahne M,Schroter M,et al. Melanoma cells express Fas(Apo- 1/CD 95 ) ligand: implications for tumor immune escape. Science, 1996,274: 4930
  • 4Hanabuchi S,kayanagi M, kawasaki A, et al. Fas and its ligand is a general mechanism of T-cell mediated cytoxicity. Proc Natl Acad Sci USA, 1994,91(11 ) :4930
  • 5Gratas C, Tohma Y, Barnas C, et al. Up-regulation of ( Apo - 1 /CD 95 ) ligand and down-regulation of Fas expression in human esophaageal cancer. Cancer Res, 1998,58(24): 5669
  • 6Natoli G, Ianni A,Costanzo A,et al. Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene, 1995,11 (6): 1157
  • 7Jodo S,kabayashi S,Nakajima Y,et al. Elevated serum levels of soluble Fas/Apo-1 (CD95)in patients with hepatocellular carcinoma. Clin Exp Immunol, 1998,112(2): 166
  • 8Faubion WA, Gores G. Death receptor in liver biology and pathobiology. Hepatology, 1999,29 ( 1 ) :461
  • 9杨友国,王海舰,郎振为.乙型肝炎肝组织中Fas抗原检测[J].徐州医学院学报,1998,18(6):461-463. 被引量:2
  • 10俞顺章.肝癌流行病学与预防.汤钊猷主编:原发性肝癌.第2版.上海:上海科学技术出版社,1998:86~112

二级参考文献5

  • 1任占平,郑绍光,陈尉麟.应用SP免疫组化染色法的体会[J].诊断病理学杂志,1994,1(3):176-176. 被引量:69
  • 2朱幼芙,J Gastroenterol Hepatol,1997年,12卷,121页
  • 3Itoh N, Yonehara, S, Ishii A, et al. The polypetide encoded by the DNA for human cell surface antigen Fas can modiate apoptosis. Cell, 1991,66(2):233.
  • 4Itoh N, Nagata S. A nevel protein domain required for apoptosis:Mutational analysis of human Fas antigen. J Biol Chem, 1993,268(15):10932.
  • 5Hiramatsu N, Hayachi N, Katayama K, et al. Immunohistochemical detection of Fas antigen in liver tissue of patient with chronic hepatitis C. Hepatology, 1994,19:1354.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部